Other benign neoplasm of uterus: Cervix uteri

CD2_BENIGN_CERVIX_UTERI

cervical carcinoma: A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D26.0& Hospital discharge: ICD-9 — 2190 Cause of death: ICD-10 — D26.0& Cause of death: ICD-9 — 2190 2 out of 7 registries used, show all original rules.	229
4. Check minimum number of events None	229
5. Include endpoints None	229
6. Filter based on genotype QC (FinnGen only)	219

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D26
Name in latin: Neoplasma benignum cervicis uteri

NAME	CD2_BENIGN_CERVIX_UTERI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D260
HD_ICD_9	2190
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D260
COD_ICD_9	2190
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other benign neoplasm of uterus: Cervix uteri based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1668	1668	-
Only index persons	1538	1538	-
Unadjusted period prevalence (%)
Whole population	0.05	0.05	-
Only index persons	0.06	0.06	-
Median age at first event (years)
Whole population	-	47.87	-
Only index persons	-	47.37	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	219	219	-
Unadjusted period prevalence (%)	0.08	0.08	-
Median age at first event (years)	47.91	47.91	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
229: Matched controls
2290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D26.0

ICD-10 Finland

Other benign neoplasm: Cervix uteri

+∞

224.6

177

2190A

ICD-9 Finland

Other benign neoplasm of uterus, Cervix uteri

+∞

54.4

N84.1

ICD-10 Finland

Polyp of cervix uteri

11.2

29.3

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

27.3

25.7

8113

FHL

Fractional scraping

4.5

14.6

LCA06

NOMESCO Finland

Biopsy of endometrium

2.8

10.6

280

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.8

8.7

219

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

3.3

7.2

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

41.3

6.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

6.2

106

686

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.3

6.0

259

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

112

2.82

5.64

1.5

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

101

2.78

5.01

1.4

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

142

2.37

4.29

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

195

2.07

3.65

2.5

3.0

19.25

34.21

u/ml

1.07

186

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

7.27

2.56

1.8

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

173

1518

1.57

2.25

7.3

7.0

80.17

75.91

u/l

0.31

162

1415

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

103

2.03

2.13

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

546

1.46

1.87

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2.13

1.85

1.5

344.80

293.82

mu/l

0.42

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.91

1.72

1.2

1.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

1.72

0.0

1.3

—

(4200892) Spirometry reversibility

143

1.76

1.69

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.85

1.66

2.6

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.13

1.63

1.2

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

381

1.47

1.59

1.8

1.6

488372533.44

16077632.90

pmol/l

0.69

311

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.17

1.58

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.93

1.54

2.3

1.6

723.29

1259.81

u/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.91

1.51

1.2

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

205

1921

1.64

1.49

4.8

4.3

5.83

5.79

mmol/l

0.23

191

1767

(3026008) Bacteria identified in Urine by Culture

652

1.37

1.46

3.1

2.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

2.55

1.46

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.09

1.46

1.8

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.17

1.44

1.2

1.8

—

(3002256) Pathology report gross observation

267

1.51

1.42

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.65

1.37

1.5

1.1

—

(3019060) Gas panel - Arterial blood

1.79

1.35

4.1

4.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

121

1369

0.75

1.31

4.0

3.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.82

1.29

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

460

1.38

1.28

3.8

3.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.44

1.25

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.44

1.25

1.3

1.6

—

(4281824) Cell count and differential, peritoneal fluid

2.34

1.19

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

180

1665

1.38

1.19

4.9

4.4

14.60

14.59

pmol/l

0.02

168

1537

(3012544) pH of Venous blood

151

1.58

1.17

3.3

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

279

1.43

1.16

2.6

5.02

4.01

e6/l

0.16

140

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

168

1.55

1.16

3.2

5.1

275.48

256.43

u/l

0.15

159

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

598

1.32

1.15

2.6

2.2

52.31

58.51

u/l

1.07

551

(3024561) Albumin [Mass/volume] in Serum or Plasma

799

1.30

1.13

5.3

3.9

36.35

36.24

g/l

0.08

746

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

193

1811

1.42

1.12

6.2

5.3

38.94

38.85

mmol/mol

0.06

179

1686

(3035350) Ketones [Presence] in Urine by Test strip

114

1001

1.28

1.04

4.2

3.6

0.00

estimate

-0.00

196

(1761482) Bacteria [#/volume] in Urine by Culture

1.95

1.03

4.8

4.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

118

1043

1.27

1.02

5.6

5.5

9.31

9.71

umol/l

0.26

113

982

(3021601) Nitrite [Presence] in Urine by Test strip

114

1005

1.27

1.00

6.4

4.9

0.00

estimate

-0.00

185

(3009261) Glucose [Presence] in Urine by Test strip

115

1015

1.27

1.00

4.2

3.6

0.15

0.00

estimate

0.48

178

(3019550) Sodium [Moles/volume] in Serum or Plasma

210

2011

1.53

0.99

14.6

13.3

139.66

139.75

mmol/l

0.21

203

1954

(3024928) Oxygen saturation in Venous blood

1.97

0.98

2.9

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

145

1319

1.27

0.96

3.5

2.8

44.28

39.46

u/l

0.29

134

1235

(3015377) Calcium [Moles/volume] in Serum or Plasma

708

1.27

0.94

3.8

3.1

2.37

2.36

mmol/l

0.15

631

(40761511) CBC panel - Blood by Automated count

215

2073

1.61

0.93

15.2

11.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.17

0.92

1.0

1.1

—

(3023368) Bacteria identified in Blood by Culture

419

1.31

0.91

5.4

3.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.68

0.90

3.2

2.6

24.51

25.15

mmol/l

0.47

(3002032) Base excess in Venous blood by calculation

145

1.49

0.88

3.1

2.8

1.14

2.10

mmol/l

1.04

123

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.60

0.86

1.7

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

163

1.46

0.86

1.3

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

120

1078

1.24

0.85

4.2

4.0

6.47

6.44

mmol/l

0.04

109

992

(3023323) Follitropin [Units/volume] in Serum or Plasma

155

1.46

0.85

1.2

1.3

25.94

30.48

iu/l

0.27

134

(3044889) 12 lead EKG panel

148

1361

1.25

0.84

3.6

3.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.77

0.83

1.1

1.5

—

(40768804) Tissue Pathology biopsy report

103

912

1.24

0.83

2.2

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.90

0.82

1.5

1.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

174

1.42

0.81

2.0

1.7

—

(3019150) Specific gravity of Urine by Refractometry

445

1.28

0.80

3.8

1.01

1.02

kg/l

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.78

0.77

4.7

3.0

11.67

62.40

u/ml

—

(3000330) Specific gravity of Urine by Test strip

100

1.54

0.75

5.1

3.0

—

(3008898) HLA-B27 [Presence]

106

0.55

0.74

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

221

1.36

0.74

1.8

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

177

1.40

0.74

2.0

1.8

—

(3038515) Glucose [Moles/volume] in Venous blood

1.87

0.74

3.3

2.5

6.81

6.86

mmol/l

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

469

1.26

0.73

1.7

0.98

0.87

mg/l

0.16

359

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.70

0.73

1.3

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1.82

0.73

3.3

2.4

1.37

1.34

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

2.02

0.73

1.8

2.3

3.84

3.89

mmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.02

0.73

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.02

0.73

1.8

2.3

—

(3035285) Chloride [Moles/volume] in Venous blood

2.02

0.73

1.8

2.3

104.60

106.28

mmol/l

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.59

0.70

4.3

3.0

49.03

46.02

0.13

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

251

1.32

0.69

1.4

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

540

1.23

0.67

3.6

1.44

5.94

mg/mmol

2.12

301

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.80

0.66

1.2

1.3

—

(3015736) pH of Urine

822

1.20

0.65

3.6

3.3

5.63

6.00

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

191

1.35

0.64

2.1

3.9

4.89

7.53

ug/l

0.33

153

(3019309) Folate [Moles/volume] in Red Blood Cells

318

1.27

0.64

1.6

1.7

1286.23

1230.94

nmol/l

0.12

229

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

207

2004

1.34

0.61

4.7

2.83

2.85

mmol/l

0.13

192

1856

(3023103) Potassium [Moles/volume] in Serum or Plasma

208

2016

1.35

0.60

14.8

13.4

3.95

3.93

mmol/l

0.38

201

1953

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

215

2095

1.43

0.59

11.0

10.0

24.22

23.74

u/l

0.20

206

2022

(3045424) Erythrocytes [Presence] in Urine

1.73

0.58

1.2

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

124

1.40

0.57

1.9

1.6

—

(3022145) Colonoscopy Study observation

238

0.74

0.56

1.6

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.64

0.56

1.3

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.59

0.54

1.3

1.6

—

(3022313) Gas panel - Capillary blood

1.47

0.54

3.1

3.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

785

1.17

0.53

4.2

3.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.55

0.53

1.2

6.78

19.44

u/l

—

(40768797) Stomach Pathology biopsy report

312

0.78

0.53

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

376

0.80

0.52

2.4

2.5

6.94

8.54

e6/l

0.19

336

(40761535) Cells panel - Urine sediment

153

1.34

0.52

2.4

3.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

226

1.27

0.51

1.5

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

105

968

1.16

0.48

3.3

2.8

81.65

77.09

ug/l

0.18

903

(3013650) Neutrophils [#/volume] in Blood by Automated count

124

1158

1.15

0.47

8.2

8.7

3.83

3.93

e9/l

0.23

109

1022

(4035726) Immunohistochemistry procedure

184

1.28

0.45

1.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

1.41

0.45

3.7

2.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

648

1.16

0.45

2.8

2.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

267

1.23

0.45

2.0

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

105

972

1.15

0.45

6.3

5.6

1.24

1.23

mmol/l

0.90

829

(3004716) Salmonella sp identified in Stool by Organism specific culture

127

0.70

0.44

1.9

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.63

0.43

1.4

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

204

1.25

0.43

1.5

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.57

0.42

1.2

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

468

1.17

0.42

2.9

2.0

2.80

3.21

mg/l

0.74

397

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

461

0.84

0.42

1.8

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

450

0.84

0.41

1.7

1.5

21.29

22.65

nmol/l

0.27

375

(3033658) Prothrombin time (PT) actual/Normal

481

0.84

0.41

3.4

3.2

92.05

97.03

0.88

472

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

1.22

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.41

0.0

2.6

—

0.82

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.48

0.40

2.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.40

0.0

2.3

—

(3022621) pH of Urine by Test strip

133

1.30

0.40

5.2

2.7

—

(3013115) Eosinophils [#/volume] in Blood

111

1039

1.13

0.39

4.7

5.5

0.18

e9/l

0.06

101

926

(21494755) Public health laboratory ask at order entry panel

198

1.24

0.38

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.34

0.38

1.9

1.5

—

(3000991) Gas panel - Venous blood

116

1.31

0.38

3.5

6.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

569

1.15

0.38

2.3

2.0

104.02

135.54

u/l

1.07

535

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.36

0.37

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.36

0.37

1.2

1.3

—

(3001604) Monocytes [#/volume] in Blood

106

992

1.13

0.37

4.7

5.3

0.53

0.54

e9/l

0.17

879

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.28

0.36

6.3

7.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.65

0.36

1.6

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.64

0.36

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

218

1.22

0.36

1.5

—

(36304419) Bacteria [Presence] in Urine

506

0.86

0.36

3.2

2.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

427

1.16

0.35

1.4

1.3

1.00

10.73

u/ml

3.07

164

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.41

0.35

1.5

1.3

—

(3006315) Basophils [#/volume] in Blood

106

995

1.12

0.35

4.7

5.3

0.04

e9/l

0.74

876

(1761868) Lipid panel - Serum or Plasma

730

1.13

0.34

3.1

2.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

0.68

0.33

1.2

2.6

30.50

41.79

u/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

888

1.12

0.33

4.8

5.0

1.23

mmol/l

0.05

811

(3000494) Fungus identified in Specimen by Culture

240

0.82

0.32

1.3

—

(3018095) Leukocytes [#/volume] in Urine

677

0.88

0.32

4.1

3.5

33.00

73.35

e6/l

0.95

447

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

221

1.20

0.32

1.2

1.4

—

(36660697) Celiac disease serology panel - Serum

186

0.79

0.32

1.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

306

1.17

0.32

1.7

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

354

1.16

0.32

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

931

1.11

0.31

5.3

6.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

111

1.28

0.31

1.1

—

106.00

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

232

1.19

0.30

4.9

5.1

—

(3012516) Albumin [Mass/volume] in Urine

511

1.13

0.29

2.9

3.0

8.60

164.93

mg/l

0.59

297

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

197

1927

1.16

0.29

5.9

5.2

1.94

2.44

mu/l

0.38

184

1784

(3045414) Leukocytes [Presence] in Urine

1.29

0.28

3.3

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.33

0.28

1.3

1.7

—

(3020891) Body temperature

1.28

0.28

3.0

3.7

—

(3019198) Lymphocytes [#/volume] in Blood

107

1015

1.10

0.28

4.7

5.3

1.73

2.03

e9/l

1.53

916

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

200

1961

1.16

0.26

4.2

1.57

1.59

mmol/l

0.26

190

1813

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.66

0.26

1.6

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.66

0.26

1.6

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

201

1972

1.16

0.26

4.3

4.2

4.80

4.85

mmol/l

0.34

192

1834

(3022096) Basophils/100 leukocytes in Blood

899

1.10

0.25

5.2

5.4

0.61

0.73

1.39

832

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

170

1.19

0.25

1.9

3.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

142

1.21

0.25

2.2

4.4

0.86

0.77

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

304

1.14

0.24

2.6

2.5

1.88

1.05

e6/l

0.46

163

(40768443) Skin Pathology biopsy report

1.26

0.23

1.0

1.3

—

(3000492) Spirometry study

163

1.18

0.22

1.9

1.5

—

(3025130) Human papilloma virus identified in Specimen

1.22

0.22

1.4

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.19

0.21

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.19

0.21

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

1.7

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.21

0.0

2.4

—

(3015183) Erythrocyte sedimentation rate

0.00

0.21

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.21

0.0

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

8.42

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.8

—

142.00

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.5

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.9

—

482.40

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

31.20

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.5

—

(40768441) Liver Pathology biopsy report

0.00

0.21

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

0.90

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.17

0.21

2.0

1.6

19.72

32.70

u/l

—

(3022217) INR in Platelet poor plasma by Coagulation assay

797

1.09

0.21

17.2

10.0

1.22

1.15

inr

0.28

236

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.20

0.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.20

0.0

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.20

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.23

0.20

1.2

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

191

1876

1.11

0.19

3.8

3.7

1.26

1.23

mmol/l

0.28

177

1727

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.16

0.19

2.2

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

1.16

0.19

5.0

3.4

3.90

3.84

mmol/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.25

0.19

1.9

2.0

0.84

0.64

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

128

1.18

0.18

2.7

2.4

112.93

144.61

ng/l

0.31

115

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

456

1.09

0.18

2.1

1.5

—

(40758558) Short blood count panel - Blood

515

0.91

0.18

6.6

6.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

157

1.16

0.18

1.9

2.8

10.89

10.08

g/l

0.54

146

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

234

1.13

0.17

4.7

4.1

34.13

34.50

0.05

144

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.13

0.17

1.0

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

674

1.08

0.17

3.3

3.4

179.25

25.90

ng/l

0.47

433

(3037121) Protein [Mass/volume] in Urine

0.71

0.17

1.6

2.7

—

0.21

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.71

0.17

1.8

1.2

—

2.36

—

(3003694) ABO and Rh group [Type] in Blood

547

1.08

0.16

1.5

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

136

1396

0.94

0.16

5.8

4.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.10

0.16

1.9

2.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.77

0.16

1.8

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.74

0.15

1.3

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.19

0.15

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

181

0.88

0.15

1.1

1.2

215.04

170.91

iu/ml

—

(3009508) Creatinine [Moles/volume] in Urine

560

1.07

0.14

2.7

2.8

7.08

6.88

mmol/l

0.11

466

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.20

0.14

1.9

2.0

1.12

1.06

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

423

1.08

0.14

1.3

15.68

35.90

iu/ml

2.01

146

(3025941) Bacteria identified in Stool by Culture

117

0.85

0.13

1.8

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

110

0.81

0.13

1.9

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

110

0.81

0.13

1.2

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

939

1.06

0.13

5.2

5.3

57.45

56.37

0.42

881

(3002582) Erythrocytes [#/volume] in Urine

553

1.07

0.12

3.0

2.9

9.91

48.47

e6/l

1.82

405

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

191

1887

1.07

0.11

10.6

11.5

82.16

83.18

ml/min/173m2

0.29

147

1525

(3019069) Monocytes/100 leukocytes in Blood

932

1.05

0.11

5.7

5.6

8.32

8.20

0.13

871

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

938

0.95

0.11

2.7

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

784

1.05

0.10

1.9

111.49

99.29

pmol/l

1.03

365

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

349

1.07

0.10

3.5

3.4

229.75

150.68

ng/l

0.17

243

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

2.4

2.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

126

1.12

0.09

1.1

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.11

0.09

1.7

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

1.09

0.09

2.3

2.5

—

(3019225) pH of Specimen

175

1.09

0.08

3.2

4.1

—

(3021589) Normoblasts [#/volume] in Blood

878

1.04

0.08

7.0

8.6

0.00

e9/l

1.29

729

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.78

0.08

1.8

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.78

0.08

1.8

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.78

0.08

1.8

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.78

0.08

1.8

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

509

0.95

0.08

3.0

2.7

0.41

0.44

e6/l

0.08

366

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.85

0.08

1.5

1.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

949

1.04

0.07

5.5

26.76

29.17

1.51

893

(3036489) Thrombin time

0.79

0.07

1.2

2.2

20.00

21.00

—

(40768793) Breast Pathology biopsy report

0.87

0.07

1.4

1.3

—

(3042936) Bacteria identified in Isolate by Culture

254

0.94

0.06

2.0

1.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

151

1528

0.97

0.06

4.8

4.1

11.88

11.16

mm/h

0.35

139

1407

(40761536) Microorganisms panel - Urine sediment

158

1.08

0.06

3.4

3.6

—

(3029937) Albumin [Presence] in Urine by Test strip

534

1.04

0.06

3.4

3.9

0.00

estimate

-0.00

186

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

172

0.92

0.06

2.7

2.3

—

21.30

—

(3001019) Free T4 and TSH panel - Serum or Plasma

151

0.92

0.05

1.1

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

159

1.07

0.05

2.4

4.4

0.71

0.67

—

(3018418) pH of Serum or Plasma

635

0.97

0.05

3.9

3.8

7.40

0.04

114

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

201

0.94

0.04

1.5

1.6

—

(3013512) EKG study

527

1.03

0.04

4.7

3.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

201

2000

1.04

0.03

15.0

12.2

19.49

19.51

mg/l

0.00

159

1525

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

531

0.97

0.03

1.3

0.51

2.05

u/ml

1.14

150

(3044640) Blood type and Crossmatch panel - Blood

619

1.02

0.03

2.0

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

202

1.04

0.02

2.3

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

242

1.04

0.02

3.5

2.2

20.07

22.43

0.44

205

(3014576) Chloride [Moles/volume] in Serum or Plasma

193

1.04

0.01

4.4

5.1

106.30

103.88

mmol/l

1.77

193

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

912

1.01

0.01

2.2

2.3

80.53

78.78

nmol/l

0.17

818

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

119

1.01

0.00

1.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

149

1.01

0.00

2.5

4.6

0.00

0.09

—

(3026782) Osmolality of Urine

347

1.01

0.00

3.1

2.6

550.40

536.55

mosm/kgh2o

0.13

296

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

557

1.01

0.00

1.7

1.6

1.46

1.34

mmol/l

0.60

474

(3025159) Blasts/100 leukocytes in Blood

146

1.03

0.00

2.4

4.5

0.20

0.18

—

(3041096) Erythrocytes [Presence] in Urine by Automated

565

0.99

0.00

4.1

3.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

145

0.96

0.00

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

11.56

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.02

0.00

1.5

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

3.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

1.59

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(3045716) Anion gap in Serum or Plasma

0.00

0.0

1.1

—

7.10

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.98

-0.00

7.0

6.7

1.58

1.38

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.99

-0.00

7.0

6.8

1.09

0.68

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

-0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.00

-0.00

1.8

1.6

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1.02

-0.00

1.0

1.1

3.34

3.87

mmol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

0.94

-0.00

1.7

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.92

-0.00

1.0

1.2

553.60

360.21

mg/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.86

-0.00

1.8

1.1

—

40.49

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

8.9

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

2.22

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

-0.00

0.0

1.6

—

(3028300) Cannabinoids [Presence] in Urine

0.94

-0.00

1.8

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

0.89

-0.00

6.2

2.6

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.92

-0.00

1.8

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(1002224) Polysomnography panel

1.00

-0.00

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

178.00

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

480

1.00

-0.00

2.3

3.0

600.78

838.24

ng/l

0.82

404

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.98

-0.00

1.6

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.2

—

1.20

—

(3027944) Amphetamines [Presence] in Urine

0.92

-0.00

1.7

1.2

—

(3027008) Opiates [Presence] in Urine

0.94

-0.00

1.7

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1.00

-0.00

1.2

33.60

87.67

e6/l

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.01

-0.00

7.0

6.9

95.76

95.06

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.90

-0.00

7.3

4.8

24.16

25.15

mmol/l

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

2.0

—

71.20

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.96

-0.00

2.4

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

1415.13

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

3.5

—

47.63

—

(3007164) IgA [Mass/volume] in Serum or Plasma

460

1.00

-0.00

1.3

1.5

2.24

2.27

g/l

0.05

280

(3016879) Cocaine [Presence] in Urine

0.97

-0.00

1.7

1.2

—

(4034850) Laboratory test

0.98

-0.00

7.0

7.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.87

-0.00

1.0

1.1

—

(3024471) HLA-A [Type]

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CERVIX_UTERI and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CERVIX_UTERI	1.246 [0.97, 1.6]	0.081
Birth year	0.996 [0.99, 1.0]	0.33

During the follow-up period (1.1.1998 — 31.12.2019), 75 out of 822 females with CD2_BENIGN_CERVIX_UTERI died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CERVIX_UTERI.

N-year risk	Females	Males
1	0.128%	No data
5	0.776%	No data
10	2.011%	No data
15	3.774%	No data
20	6.605%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CERVIX_UTERI – Other benign neoplasm of uterus: Cervix uteri

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other benign neoplasm of uterus: Cervix uteri

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints